These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34748870)

  • 21. Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis.
    Kähkönen TE; Halleen JM; Bernoulli J
    Cells; 2021 Jun; 10(6):. PubMed ID: 34204474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches.
    Özdemir BC; Hensel J; Secondini C; Wetterwald A; Schwaninger R; Fleischmann A; Raffelsberger W; Poch O; Delorenzi M; Temanni R; Mills IG; van der Pluijm G; Thalmann GN; Cecchini MG
    PLoS One; 2014; 9(12):e114530. PubMed ID: 25485970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research progress of bone-targeted drug delivery system on metastatic bone tumors.
    Hu B; Zhang Y; Zhang G; Li Z; Jing Y; Yao J; Sun S
    J Control Release; 2022 Oct; 350():377-388. PubMed ID: 36007681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The critical role of the bone microenvironment in cancer metastases.
    Casimiro S; Guise TA; Chirgwin J
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):71-81. PubMed ID: 19616059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current trials using bone-targeting agents in prostate cancer.
    Tu SM; Lin SH
    Cancer J; 2008; 14(1):35-9. PubMed ID: 18303481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD8
    Monteiro AC; Bonomo A
    Bone; 2021 Sep; 150():116014. PubMed ID: 34022456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Balancing the Scales: The Dual Role of Interleukins in Bone Metastatic Microenvironments.
    Dawalibi A; Alosaimi AA; Mohammad KS
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.
    Nordstrand A; Bovinder Ylitalo E; Thysell E; Jernberg E; Crnalic S; Widmark A; Bergh A; Lerner UH; Wikström P
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: evidence from in vivo models.
    Wang N; Docherty FE; Brown HK; Reeves KJ; Fowles AC; Ottewell PD; Dear TN; Holen I; Croucher PI; Eaton CL
    J Bone Miner Res; 2014 Dec; 29(12):2688-96. PubMed ID: 24956445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer bone metastases are attenuated in a Tgif1-deficient bone microenvironment.
    Haider MT; Saito H; Zarrer J; Uzhunnumpuram K; Nagarajan S; Kari V; Horn-Glander M; Werner S; Hesse E; Taipaleenmäki H
    Breast Cancer Res; 2020 Apr; 22(1):34. PubMed ID: 32272947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bridging the Gap in Understanding Bone Metastasis: A Multifaceted Perspective.
    Elaasser B; Arakil N; Mohammad KS
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
    Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
    Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
    Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
    Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis management.
    Nakajima K; Kho DH; Yanagawa T; Zimel M; Heath E; Hogan V; Raz A
    Cancer Metastasis Rev; 2016 Jun; 35(2):333-46. PubMed ID: 27067726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions.
    Shin HS; Sun HJ; Whang YM; Park YJ; Park DJ; Cho SW
    Thyroid; 2021 May; 31(5):760-771. PubMed ID: 32791889
    [No Abstract]   [Full Text] [Related]  

  • 36. The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease.
    Turner CJ; Edwards CM
    Curr Osteoporos Rep; 2016 Oct; 14(5):170-7. PubMed ID: 27566487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumors.
    Chen S; Lei J; Mou H; Zhang W; Jin L; Lu S; Yinwang E; Xue Y; Shao Z; Chen T; Wang F; Zhao S; Chai X; Wang Z; Zhang J; Zhang Z; Ye Z; Li B
    Front Immunol; 2024; 15():1335366. PubMed ID: 38464516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer.
    Zhang X
    Cancer Commun (Lond); 2019 Nov; 39(1):76. PubMed ID: 31753020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging therapies in bone metastasis.
    Clément-Demange L; Clézardin P
    Curr Opin Pharmacol; 2015 Jun; 22():79-86. PubMed ID: 25935860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells.
    Chiovaro F; Martina E; Bottos A; Scherberich A; Hynes NE; Chiquet-Ehrismann R
    Int J Cancer; 2015 Oct; 137(8):1842-54. PubMed ID: 25868708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.